10-K/A: NexGel Inc. Files Amendment to 2023 Annual Report to Include Management's Internal Control Report

NexGel Inc. has filed an amendment to its 2023 annual report to include management's report on internal control over financial reporting, which was inadvertently omitted from the original filing.

Summary

• NexGel, Inc. filed an amendment to its 2023 Annual Report on Form 10-K to include management's annual report on internal control over financial reporting.
• The original report, filed on April 10, 2024, inadvertently omitted this required disclosure.
• The omission had no impact on the consolidated financial statements or other disclosures in the original report.
• Management has confirmed that they had adequate internal controls in place at the time and complied with the established procedures.
• The amendment includes certifications from the CEO and CFO regarding the accuracy of the report and the effectiveness of internal controls.
• The company's disclosure controls and procedures were deemed effective as of December 31, 2023.
• There were no changes in internal control over financial reporting during the fiscal year ended December 31, 2023, that materially affected or are likely to materially affect the company's internal control over financial reporting.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document is a correction of a previous error. While the error is a negative, the company has taken steps to rectify it.

Positives

• The company has corrected the omission of the internal control report in a timely manner.
• Management has confirmed the effectiveness of their internal controls over financial reporting.
• The amendment did not require any changes to the previously reported financial statements.
• The company's disclosure controls and procedures were deemed effective as of December 31, 2023.

Negatives

• The initial omission of the internal control report indicates a lapse in the company's reporting procedures.
• The company had to file an amendment to correct the error, which may raise concerns about attention to detail.

Risks

• While the omission was corrected, it could raise questions about the company's internal control processes.
• Future reporting errors could erode investor confidence.
• The company needs to ensure all required disclosures are included in future filings to avoid similar issues.

Future Outlook

The company has not updated or amended any other disclosures contained in the original report to reflect any events which occurred after April 10, 2024, other than as expressly indicated in this Amendment.

Management Comments

• Management is aware of its responsibility for establishing adequate internal controls over financial reporting.
• Management had such internal controls in place at that time, and complied with the procedures established by the internal controls framework.
• The specific disclosure item was inadvertently omitted from the Original Report as we had previously relied on an exemption established by the SEC for newly public companies that allowed us to exclude managements report on internal control over financial reporting.

Industry Context

This amendment is a standard regulatory filing to correct an error in the original report, and is not indicative of any broader industry trend.

Comparison to Industry Standards

• The requirement to file an internal control report is standard for public companies in the US.
• The error and subsequent amendment are not uncommon, but companies are expected to maintain robust internal controls to prevent such issues.
• Companies like Medtronic, Johnson & Johnson, and Abbott also file similar reports as part of their annual filings, and are expected to have robust internal controls.

Stakeholder Impact

• Shareholders may have slight concerns about the initial reporting error, but the company's prompt correction should mitigate these concerns.
• Employees involved in financial reporting will need to ensure greater attention to detail in future filings.

Key Dates

Keywords

internal control, financial reporting, amendment, disclosure controls, Sarbanes-Oxley, Form 10-K, NexGel, compliance